Becton, Dickinson and Company (BDX) – Strong Base business leverage growth
in Company Report , Healthcare & Life Sciences , Medical Devices & Equipments on February 25, 2022During Q1FY22, the company progressed their innovation pipeline, launching several new products. Examples include BD COR, where it launched molecular MX module, which fully completes the CE Mark
system.
Highlights
Valuation
– Enterprise Value
– CrispIdea Forecast
– Economic Value Added Analysis
– DCF Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum
Actual & Historical Performance
– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– Key Developments
– M&A Deals
Peer Performance
– Summary
– Profitability
– Growth
– Price Performance
Ownership
Stock Price Performance
CrispIdea Coverage\
No of Pages : 36
Recent Blog Posts
Related Products
Popular & Trending
Featured Products
